Paradigm BioCapital Advisors LP 13D and 13G filings for Arcellx, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:03 pm Purchase | 2025-12-31 | 13G | ARCELLX INC ACLX | Paradigm BioCapital Advisors LP | 5,724,016 9.900% | 924,016 (+19.25%) | Filing |
| 2024-11-14 4:35 pm Purchase | 2024-09-30 | 13G | ARCELLX INC ACLX | Paradigm BioCapital Advisors LP | 4,800,000 8.900% | 1,141,376 (+31.20%) | Filing |
| 2024-02-14 5:57 pm Purchase | 2023-12-31 | 13G | ARCELLX INC ACLX | Paradigm BioCapital Advisors LP | 3,658,624 7.000% | 1,235,924 (+51.01%) | Filing |
| 2023-07-21 4:44 pm Purchase | 2023-07-11 | 13G | ARCELLX INC ACLX | Paradigm BioCapital Advisors LP | 2,422,700 5.050% | 2,422,700 (New Position) | Filing |